| Primary |
| Product Used For Unknown Indication |
17.4% |
| Haemorrhage |
11.4% |
| Acquired Haemophilia |
10.7% |
| Haemophilia |
7.4% |
| Coagulopathy |
5.4% |
| Factor Viii Deficiency |
5.4% |
| Anaphylactoid Syndrome Of Pregnancy |
4.7% |
| Post Procedural Haemorrhage |
4.7% |
| Haemophilia A With Anti Factor Viii |
4.0% |
| Hypertension |
4.0% |
| Pulmonary Haemorrhage |
4.0% |
| Prophylaxis |
3.4% |
| Factor Vii Deficiency |
2.7% |
| Pulmonary Embolism |
2.7% |
| Acquired Haemophilia With Anti Fviii, Xi, Or Xiii |
2.0% |
| Haemarthrosis |
2.0% |
| Immunosuppression |
2.0% |
| Pain |
2.0% |
| Postpartum Haemorrhage |
2.0% |
| Pruritus |
2.0% |
|
| Death |
21.7% |
| Drug Ineffective |
16.9% |
| Haemorrhage |
9.6% |
| Haemorrhage Intracranial |
4.8% |
| Multi-organ Failure |
4.8% |
| Renal Failure |
4.8% |
| Thrombosis |
4.8% |
| Sepsis |
3.6% |
| Acute Myocardial Infarction |
2.4% |
| Bleeding Time Prolonged |
2.4% |
| Brain Stem Haemorrhage |
2.4% |
| Concomitant Disease Progression |
2.4% |
| Disseminated Intravascular Coagulation |
2.4% |
| Gastrointestinal Haemorrhage |
2.4% |
| Hemiparesis |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Hypersensitivity |
2.4% |
| International Normalised Ratio Increased |
2.4% |
| Intracardiac Thrombus |
2.4% |
| Medication Error |
2.4% |
|
| Secondary |
| Haematuria |
21.2% |
| Product Used For Unknown Indication |
11.5% |
| Haemophilia |
10.6% |
| Haemorrhage |
6.2% |
| Factor Viii Deficiency |
5.3% |
| Pruritus |
5.3% |
| Prophylaxis |
4.4% |
| Pulmonary Haemorrhage |
4.4% |
| Acquired Haemophilia With Anti Fviii, Xi, Or Xiii |
3.5% |
| Arthralgia |
3.5% |
| Hypertension |
3.5% |
| Pulmonary Embolism |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Haemophilia A With Anti Factor Viii |
2.7% |
| Acquired Haemophilia |
1.8% |
| Coagulation Factor Viii Level |
1.8% |
| Factor V Deficiency |
1.8% |
| Factor Vii Deficiency |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Haemophilia B With Anti Factor Ix |
1.8% |
|
| Priapism |
21.1% |
| Retroperitoneal Haematoma |
17.5% |
| Bleeding Time Prolonged |
7.0% |
| Gastrointestinal Haemorrhage |
7.0% |
| Drug Ineffective |
5.3% |
| Hypersensitivity |
5.3% |
| Acute Myocardial Infarction |
3.5% |
| Chills |
3.5% |
| Haemorrhage |
3.5% |
| Hemiparesis |
3.5% |
| Pulmonary Haemorrhage |
3.5% |
| Pyrexia |
3.5% |
| Transient Ischaemic Attack |
3.5% |
| Coagulopathy |
1.8% |
| Death |
1.8% |
| Gastric Disorder |
1.8% |
| Haematoma |
1.8% |
| Haemorrhage Intracranial |
1.8% |
| International Normalised Ratio Increased |
1.8% |
| Multi-organ Failure |
1.8% |
|
